SOURCES SOUGHT
A -- Sources Sought for research, development, testing and evaluation to establish safety and toxicology data in a large animal model and initial safety and efficacy data in an injured human using patients presented to an Urban, Level 1 Trauma Center
- Notice Date
- 8/2/2018
- Notice Type
- Sources Sought
- NAICS
- 54172
— Research and Development in the Social Sciences and HumanitiesT
- Contracting Office
- Department of the Army, U.S. Army Medical Research Acquisition Activity, U.S. Army Medical Research Acquisition Activity, Attn: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014, Maryland, 21702-5014, United States
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH-18-SOCOM
- Archive Date
- 8/22/2018
- Point of Contact
- Ronald Stephen Sanford, Phone: 3016199321
- E-Mail Address
-
ronald.s.sanford2.civ@mail.mil
(ronald.s.sanford2.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- The U.S Army Medical Research Acquisition Activity (USAMRAA) in support of the United States Special Operations Command (USSOCOM), is seeking firms with the capability of continuing a follow-on effort for the research, development, testing and evaluation required to establish safety and toxicology data in a large animal model and initial safety and efficacy data in an injured human using patients presented to an Urban, Level-1 Trauma Center. This research continues the study of small-volume resuscitation therapy utilizing 3% NACI with Adenosine, Lidocaine and MG2+ (ALM) solution that offers the healthcare provider a small-volume, intravenously infusible fluid that improves cardiac function and hemodynamics in a hemorrhaging patient compared to current available treatments. The continued development of a small-volume fluid that can offer cardiac and hemodynamic stability while a patient is being transported to definitive care would revolutionize prolonged field care in combat situations as well as in the civilian realm. This follow-on effort has two aims. The first aim includes utilizing data produced in the current contract to study the safety and toxicology of efficacious dosing under the large animal model in preparation to move to pre-clinical human trials. The second aim utilizes the data obtained in the current contract and data obtained in the first aim to conduct initial safety and efficacy research in injured humans to demonstrate both safety of ALM in this patient population as well as a clear clinical benefit based on a range of parameters including: survival, amount of blood product administered, and time of return to hemodynamic normalcy. THIS IS A SOURCES SOUGHT ANNOUNCEMENT FOR PLANNING PURPOSES ONLY. The North American Industry Classification System (NAICS) is 541712, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). Interested parties should furnish the following information (1) company name, address, point of contact, telephone number, email address and website address. (2) Business type: 8(a), Women-Owned, Historically Underutilized Business Zone (Hub Zone), Small Disadvantaged, Service Disables, Veteran Owned Small Business, or small Business, etc. (3) A capabilities statement regarding similar projects completed within the last five (5) years; minimum information must include the following: final contract price, project location with a brief description of the project and (4) CAGE Code, DUNS Number and a list of Government solicitation sites that your company is available on (i.e. FedBizOps, GSA eBuy, GWAC, FedBid, NASASEWP, NITACC etc.). Electronic versions of your statement, fifteen (15) pages or less shall be submitted via email to ronald.s.sanford2.civ@mail.mil. No telephone calls will be accepted. Capability Statements must include proof that the contractor is capable of providing the requirement as outlined above. Responses are due NO LATER THAN 07 AUGUST 2018 4:30 PM Eastern Time. MARKET RESEARCH IS BEING CONDUCTED to determine if there are businesses with the capabilities and experience to perform the required work. USAMRAA will use information obtained through this synopsis to develop an acquisition strategy. THIS IS NOT A SOLICITATION ANNOUNCEMENT FOR PROPOSALS AND NO CONTRACT WILL BE AWARDED FROM THIS ANNOUNCEMENT. NO REIMBURSEMENT WILL BE MADE FOR ANY COSTS ASSOCIATED WITH PROVIDING INFORMATION IN RESPONSE TO THIS ANNOUNCEMENT. Please do not respond with brochures, advertisements or other generic material. These will not be considered as a capability statement.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/W81XWH-18-SOCOM/listing.html)
- Record
- SN05017465-W 20180804/180802231129-9cc890575a06152ac0e22056894dc9ed (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |